Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid

References

• Alarcon de la Lastra C, Martin MJ, Motilva V. (1994). Antiulcer and gastroprotective effects of quercetin: a gross and histologic study. Pharmacology 48:56–62
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. (2013). Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett [Epub ahead of print]. doi: 10.1016/j.canlet.2013.02.032
   Web of Science ®Google Scholar
• Arora A, Nair MG, Strasburg GM. (1998). Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 24:1355–63
   PubMed Web of Science ®Google Scholar
• Baka E, Comer JE, Takacs-Novak K. (2008). Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 46:335–41
   PubMed Web of Science ®Google Scholar
• Beil W, Birkholz C, Sewing KF. (1995). Effects of flavonoids on parietal cell acid secretion, gastric mucosal prostaglandin production and Helicobacter pylori growth. Arzneimittelforschung 45:697–700
   PubMed Web of Science ®Google Scholar
• Carluccio MA, Ancora MA, Massaro M, et al. (2007). Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol 293:H2344–54
   PubMed Web of Science ®Google Scholar
• Chen HT, Neerman MF, Parrish AR, Simanek EE. (2004). Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 126:10044–8
   PubMed Web of Science ®Google Scholar
• Cheng Y, Li M, Xu T. (2008a). Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies. Eur J Med Chem 43:1791–5
   PubMed Web of Science ®Google Scholar
• Cheng Y, Xu Z, MA M, XU T. (2008b). Dendrimers as drug carriers: applications in different routes of drug administration. J Pharm Sci 97:123–43
   PubMed Web of Science ®Google Scholar
• Curcio M, Cirillo G, Parisi OI, et al. (2012). Quercetin-imprinted nanospheres as novel drug delivery devices. J Funct Biomater 3:269–82
   PubMedGoogle Scholar
• Dajas F. (2012). Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol 143:383–96
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS, Patere S, et al. (2011). Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol Pharm 8:716–26
   PubMed Web of Science ®Google Scholar
• D'Emanuele A, Attwood D. (2005). Dendrimer-drug interactions. Adv Drug Deliv Rev 57:2147–62
   PubMed Web of Science ®Google Scholar
• Devarakonda B, Hill RA, De Villiers MM. (2004). The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. Int J Pharm 284:133–40
   PubMed Web of Science ®Google Scholar
• Domanski DM, Klajnert B, Bryszewska M. (2004). Influence of PAMAM dendrimers on human red blood cells. Bioelectrochemistry 63:189–91
   PubMed Web of Science ®Google Scholar
• El-Sayed M, Ginski M, Rhodes C, Ghandehari H. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 81:355–65
   PubMed Web of Science ®Google Scholar
• El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. (2003). Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm 265:151–7
   PubMed Web of Science ®Google Scholar
• Goldberg DS, Vijayalakshmi N, Swaan PW, Ghandehari H. (2011). G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity. J Controlled Release 150:318–25
   PubMed Web of Science ®Google Scholar
• Huang X, Wu Z, Gao W, et al. (2011). Polyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin. Drug Dev Ind Pharm 37:419–27
   PubMed Web of Science ®Google Scholar
• Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. (2004). Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2:2138–45
   PubMed Web of Science ®Google Scholar
• Jackson CL, Chanzy HD, Booy FP, et al. (1998). Visualization of dendrimer molecules by transmission electron microscopy (TEM): staining methods and cryo-TEM of vitrified solutions. Macromolecules 31:6259–65
   Web of Science ®Google Scholar
• Jullian C, Moyano L, Yanez C, Olea-Azar C. (2007). Complexation of quercetin with three kinds of cyclodextrins: an antioxidant study. Spectrochim Acta A Mol Biomol Spectrosc 67:230–4
   PubMed Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Li L. (2011). Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf B 88:121–30
   PubMed Web of Science ®Google Scholar
• Ke W, Zhao Y, Huang R, et al. (2008). Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J Pharm Sci 97:2208–16
   PubMed Web of Science ®Google Scholar
• Khonkarn R, Mankhetkorn S, Hennink WE, Okonogi S. (2011). PEG-OCL micelles for quercetin solubilization and inhibition of cancer cell growth. Eur J Pharm Biopharm 79:268–75
   PubMed Web of Science ®Google Scholar
• Kim HP, Mani I, Iversen L, Ziboh VA. (1998). Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot Essent Fatty Acids 58:17–24
   PubMed Web of Science ®Google Scholar
• Kitchens KM, Foraker AB, Kolhatkar RB, et al. (2007). Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res 24:2138–45
   PubMed Web of Science ®Google Scholar
• Kitchens KM, Kolhatkar RB, Swaan PW, et al. (2006). Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: influence of size, charge and fluorescent labeling. Pharm Res 23:2818–26
   PubMed Web of Science ®Google Scholar
• Klajnert B, Bryszewska M. (2001). Dendrimers: properties and applications. Acta Biochim Pol 48:199–208
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kawamoto S, Saga T, et al. (2001). Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med 46:781–8
   PubMed Web of Science ®Google Scholar
• Kojima C, Kono K, Maruyama K, Takagishi T. (2000). Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjug Chem 11:910–17
   PubMed Web of Science ®Google Scholar
• Kolhe P, Misra E, Kannan RM, et al. 2003. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm 259:143–60
   PubMed Web of Science ®Google Scholar
• Kris-Etherton PM, Keen CL. (2002). Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 13:41–9
   PubMed Web of Science ®Google Scholar
• Kumari A, Kumar V, Yadav SK. (2012). Plant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approach. PLoS One 7:1
   Google Scholar
• Lee KM, Hwang MK, Lee DE, et al. (2010). Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 58:5815–20
   PubMed Web of Science ®Google Scholar
• Li H, Zhao X, Ma Y, et al. (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 133:238–44
   PubMed Web of Science ®Google Scholar
• Lin Y, Fujimori T, Kawaguchi N, et al. (2011). Polyamidoamine dendrimers as novel potential absorption enhancers for improving the small intestinal absorption of poorly absorbable drugs in rats. J Control Release 149:21–8
   PubMed Web of Science ®Google Scholar
• Masella R, Giovannini C, Vari R, et al. (2001). Effects of dietary virgin olive oil phenols on low density lipoprotein oxidation in hyperlipidemic patients. Lipids 36:1195–202
   PubMed Web of Science ®Google Scholar
• Milenkovic M, Arsenovic-Ranin N, Stojic-Vukanic Z, et al. (2010). Quercetin ameliorates experimental autoimmune myocarditis in rats. J Pharm Pharm Sci 13:311–19
   PubMed Web of Science ®Google Scholar
• Mizui T, Sato H, Hirose F, Doteuchi M. (1987). Effect of antiperoxidative drugs on gastric damage induced by ethanol in rats. Life Sci 41:755–63
   PubMed Web of Science ®Google Scholar
• Najlah M, Freeman S, Attwood D, D'Emanuele, A. (2007). In vitro evaluation of dendrimer prodrugs for oral drug delivery. Int J Pharm 336:183–90
   PubMed Web of Science ®Google Scholar
• Pandita D, Ahuja A, Velpandian T, et al. (2009). Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique. Pharmazie 64:301–10
   PubMed Web of Science ®Google Scholar
• Patton DL, Cosgrove Sweeney YT, Mccarthy TD, Hillier SL. (2006). Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model. Antimicrob Agents Chemother 50:1696–700
   PubMed Web of Science ®Google Scholar
• Pralhad T, Rajendrakumar K. (2004). Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. J Pharm Biomed Anal 34:333–9
   PubMed Web of Science ®Google Scholar
• Priprem A, Watanatorn J, Sutthiparinyanont S, et al. (2008). Anxiety and cognitive effects of quercetin liposomes in rats. Nanomedicine 4:70–8
   PubMed Web of Science ®Google Scholar
• Roberts JC, Bhalgat MK, Zera RT. (1996). Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. J Biomed Mater Res 30:53–65
   PubMed Web of Science ®Google Scholar
• Rotelli AE, Guardia T, Juarez AO, et al. (2003). Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 48:601–6
   PubMed Web of Science ®Google Scholar
• Shoskes DA. (1998). Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents. Transplantation 66:147–52
   PubMed Web of Science ®Google Scholar
• Silva MM, Santos MR, Caroco G, et al. (2002). Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic Res 36:1219–27
   PubMed Web of Science ®Google Scholar
• Tomalia DA. (2005). Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Progress Polym Sci 30:294–324
   Web of Science ®Google Scholar
• Tomalia DA, Baker H, Dewald J, et al. (1985). A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117–32
   Web of Science ®Google Scholar
• Wiwattanapatapee R, Carreno-Gomez B, Malik N, Duncan R. (2000). Anionic PAMAM dendrimers rapidly cross adult rat intestine in vitro: a potential oral delivery system? Pharm Res 17:991–8
   PubMed Web of Science ®Google Scholar
• Wu TH, Yen FL, Lin LT, et al. (2008). Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. Int J Pharm 346:160–8
   PubMed Web of Science ®Google Scholar
• Yiyun C, Tongwen X. (2005). Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers. Eur J Med Chem 40:1188–92
   PubMed Web of Science ®Google Scholar